Share
Journal Information
Most often read
2349
SEA 2022 standards for the comprehensive control of cardiovascular riskJ.M. Mostaza, X. Pintó, P. Armario, L. Masana, J.T. Real, P. Valdivielso, T. Arrobas-Velilla, R. Baeza-Trinidad, ... L. Vila
Clin Investig Arterioscler. 2022;34:130-79
2349
Open access
Open Article
1367
Inflammation and atherogenic markers in patients with type 2 diabetes mellitusMaría Aurora Maravilla Domínguez, María de Lourdes Zermeño González, Elias Roberto Zavaleta Muñiz, Verónica Adriana Montes Varela, Cesar Antonio Irecta Nájera, Nicté Selene Fajardo Robledo, Soraya Amalí Zavaleta Muñiz
Clin Investig Arterioscler. 2022;34:105-12
1367
Open Article
1248
Adherence to non-pharmacological treatment is associated with the goals of cardiovascular control and better eating habits in Mexican patients with type 2 diabetes mellitusLubia Velázquez-López, Paulina Segura Cid del Prado, Eloísa Colín-Ramírez, Abril Violeta Muñoz-Torres, Jorge Escobedo-de la Peña
Clin Investig Arterioscler. 2022;34:88-96
1248
Open Article
1241
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, ... Manuel Aguilar
Clin Investig Arterioscler. 2022;34:36-55
1241
Open Article
1070
HDL-cholesterol concentration and risk of SARS-CoV-2 infection in people over 75 years of age: A cohort with half a million participants from the Community of MadridCarlos Lahoz, Miguel A. Salinero-Fort, Juan Cárdenas, Fernando Rodríguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, F. Javier San Andrés-Rebollo, Ignacio Vicente, José M. Mostaza
Clin Investig Arterioscler. 2022;34:113-9
1070
Open Article
857
Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national surveyCarlos Guijarro, Fernando Civeira, José López-Miranda, Luis Masana, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso, José María Mostaza
Clin Investig Arterioscler. 2022;34:10-8
857
Open access
Open Article
727
Application of the individualized objectives defined by the European 2019 lipid guidelines in patients with type 2 diabetesDavid Martín Enguix, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, Juan Carlos Aguirre Rodríguez
Clin Investig Arterioscler. 2022;34:19-26
727
Open Article
600
Challenges and perspectives of the double burden of malnutrition in Latin AmericaÁngela Hernández-Ruiz, Casandra Madrigal, María José Soto-Méndez, Ángel Gil
Clin Investig Arterioscler. 2022;34 Supl 1:3-16
600
Open Article
595
Bempedoic acid as a PPARα activator: New perspectives for hepatic steatosis treatment in a female rat experimental modelRoger Bentanachs, Ana Magdalena Velázquez, Rosa María Sánchez, Marta Alegret, Juan Carlos Laguna, Núria Roglans
Clin Investig Arterioscler. 2022;34:57-67
595
Open Article
533
Update on new forms of tobacco useJorge Francisco Gómez Cerezo, José Enrique López Paz, Jacinto Fernández Pardo
Clin Investig Arterioscler. 2022;34:330-8
533
Open access
Open Article
496
Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Clin Investig Arterioscler. 2022;34 Supl 1:23-30
496
Open Article
418
Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practiceJuan Cosín-Sales, Raquel Campuzano Ruiz, José Luis Díaz Díaz, Carlos Escobar Cervantes, María Rosa Fernández Olmo, Juan José Gómez-Doblas, José María Mostaza, Juan Pedro-Botet, ... Pedro Valdivielso
Clin Investig Arterioscler. 2022;34:253-60
418
Open Article
394
Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot studyIsabel Ortega-Madueño, Javier Modrego, Rubén Gómez-Gordo, Adriana Ortega-Hernández, Leopoldo Pérez de Isla, Juan Carlos Muñoz, M. Luisa Nieto, Dulcenombre Gómez-Garre
Clin Investig Arterioscler. 2022;34:205-15
394
Open Article
387
Why are brown bears protected against atherosclerosis even though their plasma cholesterol levels are twice that of humans?Eva Hurt-Camejo, Matteo Pedrelli
Clin Investig Arterioscler. 2022;34:322-5
387
Open access
Open Article
357
Familial chylomicronemia syndrome: The first case reported in EcuadorKarla Johana Garay García, Ricardo Javier Chong Menendez, Juan Patricio Nogueira, Jefferson Santiago Piedra Andrade
Clin Investig Arterioscler. 2022;34:326-9
357
Open Article
342
Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB studyAntonio Ruiz-García, Ezequiel Arranz-Martínez, Luis Enrique Morales-Cobos, Juan Carlos García-Álvarez, Nerea Iturmendi-Martínez, Montserrat Rivera-Teijido
Clin Investig Arterioscler. 2022;34:291-302
342
Open Article
312
DNA methylation pattern of hypertriglyceridemic subjectsMontse Guardiola, Daiana Ibarretxe, Núria Plana, Lluís Masana, Josep Ribalta
Clin Investig Arterioscler. 2022;34:27-32
312
Open Article
299
Impact of the complex humanitarian crisis on the epidemiology of the cardiometabolic risk factors in VenezuelaJuan P. González-Rivas, Jeffrey I. Mechanick, Carlos Ponte, Diana de Oliveira-Gomes, Rocio Iglesias-Fortes, Livia Machado, Maritza Duran, Maria Inés Marulanda, Ramfis Nieto-Martínez
Clin Investig Arterioscler. 2022;34:97-104
299
Open Article
294
The future of diet: what will we be eating in The future?Francisco Pérez-Jiménez
Clin Investig Arterioscler. 2022;34 Supl 1:17-22
294
Open Article
256
Is serum Osteopontin a predictor of carotid atherosclerosis severity among prevalent hemodialysis patients?Maha A. Behairy, Sahar Shawky, Reham Hamed, Somia Bawady, Hoda A. Abdelsattar, Walid Bichari
Clin Investig Arterioscler. 2022;34:75-85
256
Open Article